Genome-wide changes accompanying knockdown of fatty acid synthase in breast cancer
Open Access
- 1 January 2007
- journal article
- Published by Springer Science and Business Media LLC in BMC Genomics
- Vol. 8 (1), 168
- https://doi.org/10.1186/1471-2164-8-168
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- A Fatty Acid Synthase Blockade Induces Tumor Cell-cycle Arrest by Down-regulating Skp2Published by Elsevier BV ,2004
- Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor ActivityCancer Research, 2004
- Fatty acid synthase expression in melanomaJournal of Cutaneous Pathology, 2003
- Overexpression of fatty acid synthase is an early and common event in the development of prostate cancerInternational Journal of Cancer, 2001
- The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lungHuman Pathology, 2000
- Fatty-acid synthase and human cancer: new perspectives on its role in tumor biologyNutrition, 2000
- Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines.1998
- Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survivalHuman Pathology, 1997
- Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patientsCancer, 1996
- Fatty acid synthase, a proficient multifunctional enzymeBiochemistry, 1989